David Henry สาธารณะ
[search 0]
เพิ่มเติม
ดาวน์โหลดแอปเลย!
show episodes
 
Artwork
 
This podcast is set up to help listeners improve on those areas of their life that the most time find difficult to cope with or work on. As you journey with the host on this show, you will be amazed about the positive improvement in your life😊.
  continue reading
 
Loading …
show series
 
Quality is what consumers look out for in a product before getting it. So, does this makes sex, one of the qualities to be look out for in a relationship? My guest Alex took me on an adventure on this episode, helping my audience to understand the checklist of a relationship.
  continue reading
 
Some individuals have made it a belief that once there are in a relationship, they feel that it's something that must work out no matter what. And this belief has blinded a lot of persons from seeing the 'RED LINE IN A RELATIONSHIP'
  continue reading
 
On this episode, my guest waverly kelly was able to throw a whole lot of light on what the main concept of failure is. He said, and i quote, 'failure doesn't defines you, but rather designs you for the future. As you listen to this podcast, i hope you understand the real concept of failure.
  continue reading
 
In the final JCSO podcast for 2017, Dr David Henry, the Editor-in-Chief, discusses a round-up by Dr Linda Bosserman of cancer care in 2017 and an accompanying article on the therapeutic implications of some of the year’s landmark approvals. Continuing with the theme of therapeutic advances, he also highlights a review of the expanding treatment opt…
  continue reading
 
For the July-August issue of the Journal of Community and Supportive Oncology, the Editor-in-Chief, Dr David Henry, discusses a recap by Howard Burris, MD, of the top presentations at this year’s annual meeting of the American Society for Clinical Oncology, and a selection of articles on some of the key findings reported at the meeting. A number of…
  continue reading
 
For the May-June issue of the Journal of Community and Supportive Oncology, the Editor in Chief, Dr David Henry, discusses an editorial by Kevin Knopf, a JCSO editor, about drawing on modern portfolio theory to improve cancer care. Side effects come under scrutiny this issue, with a How We Do It article on prehabilitation for lymphedema in head and…
  continue reading
 
For the March-April issue of the Journal of Community and Supportive Oncology, the Editor in Chief, Dr David Henry, discusses two informative “how-to” articles, one on the implementation of a distress management program at an oncology hospital in Puerto Rico, the other on the prevention and treatment options for mTOR inhibitor-associated stomatitis…
  continue reading
 
In his April podcast for The Journal of Community and Supportive Oncology, Editor-in-Chief Dr David Henry discusses Original Reports on olanzapine compared with fosaprepitant for the prevention of concurrent chemotherapy radiotherapy-induced nausea and vomiting and an analysis of patient-reported outcomes in prostate cancer after treatment with abi…
  continue reading
 
In David Henry’s March podcast for The Journal of Community and Supportive Oncology, he discusses a number of articles that center on patient quality of life and overall quality of care, among them, an article on opioid risk assessment in palliative care and three Original Reports, one on the impact of trimodality treatment on arm function and QoL …
  continue reading
 
For the February podcast for The Journal of Community and Supportive Oncology, Editor-in-Chief Dr David Henry examines two Original Reports, one on a collaborative investigation by scientists and members of a social network into fluoroquinolone-related neuropsychiatric and mitochondrial toxicity and another on the prognostic value of complete remis…
  continue reading
 
In his January podcast for The Journal of Community and Supportive Oncology, Editor-in-Chief Dr David Henry discusses a Commentary by Dr Thomas Strouse on the use on cannabinoids in the cancer treatment setting and a Community Translations article on the recent approval of idarucizumab as the first specific oral anticoagulant reversal agent. Also i…
  continue reading
 
Loading …

คู่มืออ้างอิงด่วน